The major form of MeCP2 has a novel N-terminus generated by alternative splicing.

MeCP2 is a methyl-CpG binding protein that can repress transcription of nearby genes. In humans, mutations in the MECP2 gene are the major cause of Rett syndrome. By searching expressed sequence tag (EST) databases we have found a novel MeCP2 splice isoform (MeCP2alpha) which encodes a distinct N-terminus. We demonstrate that the MeCP2alpha mRNA splice variant is more abundant than the previously annotated MeCP2 mRNA (MeCP2beta) in mouse tissues and human brain. Furthermore, MeCP2beta mRNA has an upstream open reading frame that inhibits its translation. As a result of these differences, >90% of MeCP2 in mouse brain is MeCP2alpha. Both protein isoforms are nuclear and colocalize with densely methylated heterochromatic foci in mouse cells. The presence of a previously unknown MeCP2 isoform has implications for the genetic screening of Rett syndrome patients and for studies of the functional significance of MeCP2.

[1]  A. Wolffe,et al.  Profiling methyl-CpG specific determinants on transcriptionally silent chromatin , 2004, Molecular Biology Reports.

[2]  Eric C. Griffith,et al.  Derepression of BDNF Transcription Involves Calcium-Dependent Phosphorylation of MeCP2 , 2003, Science.

[3]  Daisuke Hattori,et al.  DNA Methylation-Related Chromatin Remodeling in Activity-Dependent Bdnf Gene Regulation , 2003, Science.

[4]  A. Bird,et al.  DNA methylation and Rett syndrome. , 2003, Human molecular genetics.

[5]  H. Zoghbi,et al.  A mutant form of MeCP2 protein associated with human Rett syndrome cannot be displaced from methylated DNA by notch in Xenopus embryos. , 2003, Molecular cell.

[6]  Tony Kouzarides,et al.  The Methyl-CpG-binding Protein MeCP2 Links DNA Methylation to Histone Methylation* , 2003, The Journal of Biological Chemistry.

[7]  Juan I. Young,et al.  Mice with Truncated MeCP2 Recapitulate Many Rett Syndrome Features and Display Hyperacetylation of Histone H3 , 2002, Neuron.

[8]  H. Stunnenberg,et al.  In vivo repression of an erythroid‐specific gene by distinct corepressor complexes , 2002, The EMBO journal.

[9]  R. A. Drewell,et al.  Methylation-dependent silencing at the H19 imprinting control region by MeCP2. , 2002, Nucleic acids research.

[10]  B. Hagberg.  Clinical manifestations and stages of Rett syndrome. , 2002, Mental retardation and developmental disabilities research reviews.

[11]  M. Kozak,et al.  Constraints on reinitiation of translation in mammals. , 2001, Nucleic acids research.

[12]  A. Wolffe,et al.  Analysis of chromatin-immunopurified MeCP2-associated fragments. , 2001, Biochemical and biophysical research communications.

[13]  M. Groudine,et al.  Methylation-Mediated Proviral Silencing Is Associated with MeCP2 Recruitment and Localized Histone H3 Deacetylation , 2001, Molecular and Cellular Biology.

[14]  P. Jones,et al.  Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation. , 2001, Nucleic acids research.

[15]  R. Jaenisch,et al.  Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice , 2001, Nature Genetics.

[16]  J. Spiess,et al.  Inhibition of corticotropin releasing hormone type-1 receptor translation by an upstream AUG triplet in the 5' untranslated region. , 2001, Molecular pharmacology.

[17]  A. Bird,et al.  A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome , 2001, Nature Genetics.

[18]  A. Wolffe,et al.  MeCP2 driven transcriptional repression in vitro: selectivity for methylated DNA, action at a distance and contacts with the basal transcription machinery. , 2000, Nucleic acids research.

[19]  A. Poustka,et al.  Comparative sequence analysis of the MECP2-locus in human and mouse reveals new transcribed regions , 2000, Mammalian Genome.

[20]  H. Zoghbi,et al.  Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2 , 1999, Nature Genetics.

[21]  A. Geballe,et al.  Translational Control by an Upstream Open Reading Frame in the HER-2/neu Transcript* , 1999, The Journal of Biological Chemistry.

[22]  A. Poustka,et al.  A complex pattern of evolutionary conservation and alternative polyadenylation within the long 3"-untranslated region of the methyl-CpG-binding protein 2 gene (MeCP2) suggests a regulatory role in gene expression. , 1999, Human molecular genetics.

[23]  R. Lovell-Badge,et al.  Generation of purified neural precursors from embryonic stem cells by lineage selection , 1998, Current Biology.

[24]  A. Bird,et al.  Identification and Characterization of a Family of Mammalian Methyl-CpG Binding Proteins , 1998, Molecular and Cellular Biology.

[25]  J. Strouboulis,et al.  Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription , 1998, Nature Genetics.

[26]  Colin A. Johnson,et al.  Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex , 1998, Nature.

[27]  A. Bird,et al.  MeCP2 Is a Transcriptional Repressor with Abundant Binding Sites in Genomic Chromatin , 1997, Cell.

[28]  A. Bird,et al.  DNA methylation specifies chromosomal localization of MeCP2 , 1996, Molecular and cellular biology.

[29]  S. Cross,et al.  Genetic and physical mapping of a gene encoding a methyl CpG binding protein, Mecp2, to the mouse X chromosome. , 1994, Genomics.

[30]  A. Bird,et al.  Dissection of the methyl-CpG binding domain from the chromosomal protein MeCP2. , 1993, Nucleic acids research.

[31]  K. Davies,et al.  Trinucleotide repeat amplification and hypermethylation of a CpG island in FRAXE mental retardation , 1993, Cell.

[32]  A. Bird,et al.  Purification, sequence, and cellular localization of a novel chromosomal protein that binds to Methylated DNA , 1992, Cell.

[33]  R. Derynck,et al.  Inhibition of translation of transforming growth factor-beta 3 mRNA by its 5' untranslated region , 1991, Molecular and cellular biology.